Abstract: The present invention relates to the ability of constitutively active Notch 2 to function as an inhibitor of breast cancer. The invention provides methods and compositions for inhibiting breast cancer cells by using hNotch2ICD polypeptides.
Type:
Grant
Filed:
October 19, 2007
Date of Patent:
April 20, 2010
Assignee:
Maine Medical Research Institute, a division of Maine Medical Center